Hypertension
Conditions
Interventions
None listed
Sponsors
Yokohama City University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The studies are case-control studies, cohort studies, and randomized clinical trials. (2) The studies are of patients with clinically diagnosed hypertension. (3) It includes a normotensive group as a control. (4) The study describes the recurrence of malignancy.
Exclusion criteria
Exclusion criteria: The search will be limited to solid tumors because blood cancers are rare in this topic. In addition, the following items will be used as exclusion criteria. (1) Systematic review or meta-analysis articles. (2) Case reports or case series reporting less than 50 cases. (3) The republished research literature is excluded unless the research includes new findings related to malignancy outcomes. (4) Studies published in languages other than English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the risk of solid tumor recurrence in hypertensive patients. Hazard ratios (HRs) will be calculated for the recurrence rate of solid tumors in hypertensive and normotensive patients. | — |
Countries
Japan
Contacts
Public ContactShintaro Minegishi
Yokohama City University Graduate School of Medicine Department of Cardiology
Outcome results
None listed